Girish Mahajan (Editor)

Cord Blood Registry

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Website
  
www.cordblood.com

Founded
  
1992

Cord Blood Registry wwwcordbloodcommediaFDED772F93684451B29E3619

Type
  
Subsidiary of AMAG Pharmaceuticals

Founder
  
Tom Moore and Wendy Grant

Key people
  
Geoff Crouse, President & CEO

Services
  
Cord blood stem cells preservation and research

Headquarters
  
San Bruno, California, United States

Parent organization
  
AMAG Pharmaceuticals, Inc.

Profiles

Cord Blood Registry is a biotechnology company headquartered in San Bruno, California, founded in 1992 by father and daughter Tom Moore and Wendy Grant.

CBR offers the collection, processing, and long-term cryopreservation of stem cells contained in the umbilical cord blood of newborns, as well as storage of a section of the umbilical cord.

Moore and Grant established the CBR laboratory with David T. Harris, professor of microbiology and immunology. The project began as a pilot partially sponsored by the American Cancer Society at the University of Arizona.

Cord blood is a rich source of stem cells, which have been used in the treatment of over 80 diseases, including leukemia, lymphoma and anemia. CBR processed cord blood has been used in clinical trials investigating conditions including: autism, cerebral palsy, hearing loss, pediatric stroke, and traumatic brain injury.

Cord blood registry company presentation


References

Cord Blood Registry Wikipedia